Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

2.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

3.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

4.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

5.

The pathology of incurable cancers can be predicted thanks to research.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot